-
February 6, 2024
-
February 6, 2024
-
February 6, 2024
-
March 28, 2024
-
March 28, 2024
-
March 25, 2024
Notice of the Settlement of Patent Infringement Litigation Related to Lenvatinib in the U.S.
-
March 22, 2024
-
March 21, 2024
Latest Financial Reports
Consolidated Financial Report for Third Quarter Financial Results for the Fiscal Year Ending March 31, 2024
Financial Information
Latest Presentations
- Information Meeting 2024 (March 8, 2024)
- Information Meeting (Webcast) (March 8, 2024)
- Press Conference (March 7, 2024)
- Third Quarter Financial Results for FY2023 (February 6, 2024)
- Third Quarter Financial Results for FY2023 (Webcast) (February 6, 2024)
- <Webcast> Launch of LEQEMBI in Japan (December 13, 2023)
-
Management Policy
-
Value Creation Report (Former Integrated Report) / Environmental Report / Human Capital Report
-
Financial Data
Electronic Public Notice
No corporate bonds have been issued at present.